Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Biotech Stocks

Biotech Stocks

Random
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Who’s Buying Teva Pharmaceutical Industries Ltd (NYSE:TEVA) US Assets?

Andy Parker - June 28, 2016

Weekly Biotech Report – Covering Clovis Oncology Inc (NASDAQ:CLVS) Chiasma Inc (NASDAQ:CHMA) Sarepta Therapeutics Inc (NASDAQ:SRPT) Collegium Pharmaceutical Inc. (NASDAQ:COLL)

Cempra

A Deeper Look At The Market’s Irrational Response To The Latest Cempra Release

Genmab Pockets $112 Million In Milestones From Johnson & Johnson (NYSE:JNJ)

Biotech Movers And Shakers: Cascadian Therapeutics, Inc. (NASDAQ:CASC) and Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

Alibaba Group Holding Ltd (NYSE:BABA) AliHealth To Offer Drug Tracking Software

Andy Parker - May 13, 2016 0
NEOS

Biotech Movers: Egalet Corporation (NASDAQ:EGLT) and Neos Therapeutics, Inc. (NASDAQ:NEOS)

- June 21, 2017 0

Nektar Therapeutics (NASDAQ:NKTR): Here’s What Just Happened

- March 21, 2017 0

Biotech Movers: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), Aeterna Zentaris Inc. (NASDAQ:AEZS) and...

- May 3, 2017 0

Calculating The Impact Of Akebia Therapeutics Inc (NASDAQ:AKBA)’s Pivotals

- August 11, 2016 0
Voyager

Biotech Movers: NewLink Genetics Corporation (NASDAQ:NLNK) and Endo International plc (NASDAQ:ENDP)

- June 9, 2017 0
aaap

Weekly Biotech Report – FDA Approves Advanced Accelerator Application SA(ADR) (NASDAQ:AAAP)...

David Rich - June 7, 2016 0
neos

Neos Selloff Might Be An Opportunity For A Discount – Here’s...

- November 6, 2015 0
platelet

Decsontructing The Latest The Medicines Company (NASDAQ:MDCO) Release

- October 19, 2016 0

AbbVie Inc. (NYSE:ABBV): CHMP Okays Humira As Treatment For Uveitis

Andy Parker - July 24, 2017 0
123...146Page 1 of 146

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 21, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

August 31, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

August 17, 2026

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019